臨床薬理
Online ISSN : 1882-8272
Print ISSN : 0388-1601
ISSN-L : 0388-1601
尿中N-acetyl-β-D-glucosaminidase (NAG) により示されたII型糖尿病の早期腎障害に対するDilazepdihydrochloride投与効果の検討
田中 俊一中島 茂石原 学星野 博子井上 修二高邑 裕太郎
著者情報
ジャーナル フリー

1989 年 20 巻 3 号 p. 633-637

詳細
抄録
Forty-two patients (19 men, 23 women) with NIDDM recruited from the out-patient clinic were studied to evaluate the effect of dilazep dihydrochloride (dilazep) on abnormal urinary NAG excretion. All patients, who showed persistently high NAG excretion in urine, had no other complications including hypertension, proteinuria, and clinically significant retinopathy. Patients whose HbAic or fasting plasma glucose levels had been altered over 10% of pre-administration levels throughout the observation period were excluded. The mean age was 57±12 yr (range 29-75). Blood and urinary analyses were attained before, at one month, three months, and six months after the administration of dilazep (300mg/day). In three months, urinary NAG/Cr ratio as well as NAG concentra tion were significantly reduced (P<0.001). This effect has been observed throughout the observation period of six months. No adverse effects were observed in our patients. These results suggest that dilazep is a useful drug for the improvement of latent diabetic nephropathy indicated by the abnormal NAG excretion in urine.
著者関連情報
© 日本臨床薬理学会
前の記事 次の記事
feedback
Top